Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT transplant complications working party
Penack, O. Peczynski, C. Koenecke, C. Polge, E. Potter, V. Fegueux, N. Daskalakis, M. Kroger, N. Dreger, P. Besley, C.
Penack, O.
Peczynski, C.
Koenecke, C.
Polge, E.
Potter, V.
Fegueux, N.
Daskalakis, M.
Kroger, N.
Dreger, P.
Besley, C.
Citations
Altmetric:
Abstract
Authors
Penack, O.
Peczynski, C.
Koenecke, C.
Polge, E.
Potter, V.
Fegueux, N.
Daskalakis, M.
Kroger, N.
Dreger, P.
Besley, C.
Schanz, U.
Bloor, Adrian
Ganser, A.
Forcade, E.
Corral, L. L.
Passweg, J.
Novak, U.
Moiseev, I.
Schoemans, H.
Basak, G. W.
Chabannon, C.
Sureda, A.
Averbuch, D.
Glass, B.
De la Camara, R.
Peric, Z.
Peczynski, C.
Koenecke, C.
Polge, E.
Potter, V.
Fegueux, N.
Daskalakis, M.
Kroger, N.
Dreger, P.
Besley, C.
Schanz, U.
Bloor, Adrian
Ganser, A.
Forcade, E.
Corral, L. L.
Passweg, J.
Novak, U.
Moiseev, I.
Schoemans, H.
Basak, G. W.
Chabannon, C.
Sureda, A.
Averbuch, D.
Glass, B.
De la Camara, R.
Peric, Z.
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Penack O, Peczynski C, Koenecke C, Polge E, Potter V, Fegueux N, et al. Severe Cytopenia after CD19 CAR T-Cell Therapy: A Retrospective Study from the EBMT Transplant Complications Working Party. Blood. 2022 Nov;140:4664-7. PubMed PMID: WOS:000893223204299.